The Effect of Dexamethasone 12 mg vs 6 mg on Thromboembolic Events in Patients With Critical COVID-19

PHASE3CompletedINTERVENTIONAL
Enrollment

445

Participants

Timeline

Start Date

August 27, 2020

Primary Completion Date

June 20, 2021

Study Completion Date

June 30, 2021

Conditions
COVID-19Thrombosis EmbolismBleeding
Interventions
DRUG

Dexamethasone

ATC code H02AB02

Trial Locations (1)

11883

Södersjukhuset, Stockholm

All Listed Sponsors
collaborator

Scandinavian Critical Care Trials Group

OTHER

collaborator

Copenhagen Trial Unit, Center for Clinical Intervention Research

OTHER

collaborator

Centre for Research in Intensive Care (CRIC)

OTHER

collaborator

Aarhus University Hospital

OTHER

collaborator

Aalborg University Hospital

OTHER

collaborator

Rigshospitalet, Denmark

OTHER

collaborator

Linkoeping University

OTHER_GOV

collaborator

Stockholm South General Hospital

OTHER

lead

Karolinska Institutet

OTHER

NCT05195242 - The Effect of Dexamethasone 12 mg vs 6 mg on Thromboembolic Events in Patients With Critical COVID-19 | Biotech Hunter | Biotech Hunter